Clinical ophthalmology (Auckland, N.Z.) · 2026
Efficacy of Intraoperative 9-0 Nylon Thread Insertion for Preventing Hypotony-Related Complications Following PreserFlo MicroShunt Implantation in Japanese Patients: A Comparative Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Matsuoka Takahiro, Usami Takahiro, Kaneko Hiroki
Аннотация
BACKGROUND: Early postoperative hypotony remains a significant complication following PreserFlo MicroShunt (PMS) implantation, potentially leading to serious sequelae including choroidal detachment and hypotensive maculopathy. This study evaluated the effectiveness of intraoperative 9-0 nylon thread insertion (NTI) technique in preventing hypotony-related complications.
METHODS: This retrospective comparative study included 81 eyes of 63 patients who underwent PMS implantation with mitomycin C between September 2023 and June 2025. Eyes were divided into NTI group (59 eyes, 42 patients) and Non-NTI group (22 eyes, 21 patients). The primary outcome was the incidence of composite hypotony-related complications (choroidal detachment and/or hypotensive maculopathy) during 6-month follow-up. Secondary outcomes included intraocular pressure (IOP) changes, medication score reduction, and timing of suture removal. Statistical analyses incorporated cluster correction for bilateral cases.
RESULTS: Baseline characteristics, including glaucoma subtype distribution, were comparable between groups. The composite hypotony-related complication rate was significantly lower in the NTI group (11.9% vs 54.5%, p<0.001; odds ratio 0.112, 95% CI 0.039-0.321). Kaplan-Meier analysis demonstrated superior complication-free survival in the NTI group (log-rank p<0.001, hazard ratio 0.094, 95% CI 0.035-0.252). The median IOP at postoperative day 1 was significantly higher in the NTI group (10.0 [8.0-14.0] vs 5.8 [5.0-8.5] mmHg, p<0.001), indicating effective early hypotony prevention. At 6 months, both groups achieved comparable IOP control (13.0 [10.9-14.0] vs 13.0 [11.0-16.0] mmHg, p=0.324) with medication-free rates of 74.6% and 59.1%, respectively (p=0.190).
CONCLUSION: Intraoperative 9-0 nylon thread insertion significantly reduces hypotony-related complications following PMS implantation without compromising IOP control at 6 months or medication reduction, representing a safe and effective surgical modification.
METHODS: This retrospective comparative study included 81 eyes of 63 patients who underwent PMS implantation with mitomycin C between September 2023 and June 2025. Eyes were divided into NTI group (59 eyes, 42 patients) and Non-NTI group (22 eyes, 21 patients). The primary outcome was the incidence of composite hypotony-related complications (choroidal detachment and/or hypotensive maculopathy) during 6-month follow-up. Secondary outcomes included intraocular pressure (IOP) changes, medication score reduction, and timing of suture removal. Statistical analyses incorporated cluster correction for bilateral cases.
RESULTS: Baseline characteristics, including glaucoma subtype distribution, were comparable between groups. The composite hypotony-related complication rate was significantly lower in the NTI group (11.9% vs 54.5%, p<0.001; odds ratio 0.112, 95% CI 0.039-0.321). Kaplan-Meier analysis demonstrated superior complication-free survival in the NTI group (log-rank p<0.001, hazard ratio 0.094, 95% CI 0.035-0.252). The median IOP at postoperative day 1 was significantly higher in the NTI group (10.0 [8.0-14.0] vs 5.8 [5.0-8.5] mmHg, p<0.001), indicating effective early hypotony prevention. At 6 months, both groups achieved comparable IOP control (13.0 [10.9-14.0] vs 13.0 [11.0-16.0] mmHg, p=0.324) with medication-free rates of 74.6% and 59.1%, respectively (p=0.190).
CONCLUSION: Intraoperative 9-0 nylon thread insertion significantly reduces hypotony-related complications following PMS implantation without compromising IOP control at 6 months or medication reduction, representing a safe and effective surgical modification.